{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:22:35Z","timestamp":1788009755960,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900344"],"award-info":[{"award-number":["81900344"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2018JJ3795"],"award-info":[{"award-number":["2018JJ3795"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Administration of Traditional Chinese Medicine of Hunan","award":["201335"],"award-info":[{"award-number":["201335"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The exact incidence, clinical features and uniform diagnostic criteria of exogenous insulin autoimmune syndrome (EIAS) are still unclear. The purpose of this study is to explore the clinical characteristics of EIAS and to provide a structural approach for clinical diagnosis, treatment and prevention.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The literature on EIAS in Chinese and English from 1970 to 2020 was collected for retrospective analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 122 patients (33 males and 73 females) were included in the study with a median age of 67\u00a0years (range 14\u201386) and a median HbA1c of 7.7%. EIAS mainly occurred in type 2 diabetes mellitus patients using premixed insulin. Symptoms manifested were hypoglycemia in 86.54%, recurrent episodes of symptomatic hypoglycemia in 35.58%, nocturnal hypoglycemia along with daytime hyperglycemia in 21.15% and recurrent hypoglycemia after discontinued insulin in 64.43%. The onset of symptoms occurred at night, in the early morning or during fasting, ranging from a few days to 78\u00a0months after the administration of insulin. The mean blood glucose level during the hypoglycemic phase was 2.21\u00a0mmol\/L (range 1\u20133.4), and the serum insulin levels were mainly\u2009\u2265\u2009100 U\/mL and were associated with low C-peptide levels (\u2264\u200910\u00a0ng\/ml). Insulin autoantibodies (IAAs) were positive in all EIAS patients. The 75-g extended oral glucose tolerance test (OGTT) mainly showed a diabetic curve. Pancreatic imaging was unremarkable. Withdrawal of insulin alone or combination of oral hypoglycemic agents or replacement of insulin formulations or with corticosteroid treatment eliminated hypoglycemia in a few days to 3\u00a0months. IAA turned negative in 6\u00a0months (median, range 1\u201312). No hypoglycemia episodes were observed at a median follow-up of 6\u00a0months (range 0.5\u201360).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>EIAS is an autoimmune disease caused by insulin-binding antibodies in susceptible subjects. Insulin antibodies change glucose dynamics and could increase the incidence of hypoglycemic episodes. Detection of insulin antibodies is the diagnostic test. Changing therapeutic modalities reduced the incidence of hypoglycemic episodes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13098-021-00658-z","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T13:06:05Z","timestamp":1617800765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Analysis of the clinical characteristics of insulin autoimmune syndrome induced by exogenous insulin in diabetic patients"],"prefix":"10.1186","volume":"13","author":[{"given":"Zuojun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6067-8305","authenticated-orcid":false,"given":"Chunjiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"658_CR1","first-page":"312","volume":"13","author":"Y Hirata","year":"1970","unstructured":"Hirata Y, Ishizu H, Ouchi N, et al. Insulin autoimmunity in a case of spontaneous hypoglycemia. J Jpn Diabet Soc. 1970;13:312\u201320.","journal-title":"J Jpn Diabet Soc"},{"issue":"17","key":"658_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.21037\/atm.2018.07.32","volume":"6","author":"S Censi","year":"2018","unstructured":"Censi S, Mian C, Betterle C. Insulin autoimmune syndrome: from diagnosis to clinical management. Ann Transl Med. 2018;6(17):335.","journal-title":"Ann Transl Med"},{"key":"658_CR3","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1515\/cclm-2015-1255","volume":"54","author":"AAA Ismail","year":"2016","unstructured":"Ismail AAA. The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis. Clin Chem Lab Med. 2016;54:1715\u201324.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"658_CR4","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.diabres.2008.10.015","volume":"83","author":"Y Uchigata","year":"2009","unstructured":"Uchigata Y, Hirata Y, Iwamoto Y. Drug-induced insulin autoimmune syndrome. Diabetes Res Clin Pract. 2009;83(1):e19-20.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"658_CR5","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/EC-17-0309","volume":"7","author":"X Hu","year":"2018","unstructured":"Hu X, Chen F. Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients. Endocr Connect. 2018;7(1):R47\u201355.","journal-title":"Endocr Connect"},{"issue":"1","key":"658_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/07315724.2014.976673","volume":"35","author":"R Li","year":"2016","unstructured":"Li R, Mao J, Yu K, et al. Medical nutrition therapy is effective in the management of hypoglycemia caused by insulin antibodies: a case report and literature review. J Am Coll Nutr. 2016;35(1):86\u201390.","journal-title":"J Am Coll Nutr"},{"key":"658_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3109\/08916939508993352","volume":"20","author":"Y Uchigata","year":"1995","unstructured":"Uchigata Y, Hirata Y, Omori Y. A novel concept of type VII hypersensitivity introduced by insulin autoimmune syndrome (Hirata\u2019s disease). Autoimmunity. 1995;20:207\u20138.","journal-title":"Autoimmunity"},{"issue":"4","key":"658_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/10408363.2017.1299684","volume":"54","author":"S Yazdanpanah","year":"2017","unstructured":"Yazdanpanah S, Rabiee M, Tahriri M, et al. Evaluation of glycated albumin (GA) and GA\/HbA1c ratio for diagnosis of diabetes and glycemic control: a comprehensive review. Crit Rev Clin Lab Sci. 2017;54(4):219\u201332.","journal-title":"Crit Rev Clin Lab Sci."},{"issue":"3","key":"658_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2337\/diacare.23.3.295","volume":"23","author":"M Stumvoll","year":"2000","unstructured":"Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000;23(3):295\u2013301.","journal-title":"Diabetes Care."},{"key":"658_CR10","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2147\/DMSO.S219438","volume":"13","author":"D Cappellani","year":"2020","unstructured":"Cappellani D, Macchia E, Falorni A, Marchetti P. Insulin autoimmune syndrome (Hirata Disease): a comprehensive review fifty years after its first description. Diabetes Metab Syndr Obes. 2020;13:963\u201378.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"658_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1210\/jc.2008-1410","volume":"94","author":"PE Cryer","year":"2009","unstructured":"Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009;94:709\u201328.","journal-title":"J Clin Endocrinol Metab"},{"key":"658_CR12","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1210\/jc.2007-0075","volume":"92","author":"DJ Halsall","year":"2007","unstructured":"Halsall DJ, Mangi M, Soos M, et al. Hypoglycemia due to an insulin binding antibody in a patient with an IgA-kappa myeloma. J Clin Endocrinol Metab. 2007;92:2013\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"658_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1046\/j.1525-1381.1999.09114.x","volume":"111","author":"BM Brooks-Worrell","year":"1999","unstructured":"Brooks-Worrell BM, Nielson D, Palmer JP. Insulin autoantibodies and insulin antibodies have similar binding characteristics. Proc Assoc Am Physicians. 1999;111:92\u20136.","journal-title":"Proc Assoc Am Physicians"},{"key":"658_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1515\/CCLM.2008.031","volume":"46","author":"AAA Ismail","year":"2008","unstructured":"Ismail AAA. The double whammy of endogenous insulin antibodies in non-diabetic subjects. Clin Chem Lab Med. 2008;46:153\u20136.","journal-title":"Clin Chem Lab Med."},{"key":"658_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00592-009-0135-2","volume":"47","author":"S Oak","year":"2010","unstructured":"Oak S, Phan TH, Gilliam LK, et al. Animal insulin therapy induces a biased insulin antibody response that persists for years after introduction of human insulin. Acta Diabetol. 2010;47:131\u20135.","journal-title":"Acta Diabetol"},{"key":"658_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tips.2009.11.001","volume":"31","author":"M Sauerborn","year":"2010","unstructured":"Sauerborn M, Brinks V, Jiskoot W, Schellekens H. Immunological mechanism underlying the immune response to recombinant human protein therapeutics. Trends Pharmacol Sci. 2010;31:53\u20139.","journal-title":"Trends Pharmacol Sci"},{"key":"658_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/diab.36.1.1","volume":"36","author":"K Dahl-Jorgensen","year":"1987","unstructured":"Dahl-Jorgensen K, Torjesen P, Hanssen KF, et al. Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment. Diabetes. 1987;36:1\u20135.","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"658_CR18","first-page":"43","volume":"6","author":"G Schernthaner","year":"1983","unstructured":"Schernthaner G, Borkenstein M, Fink M, et al. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Diabetes Care. 1983;6(Suppl 1):43\u20138.","journal-title":"Diabetes Care"},{"key":"658_CR19","first-page":"645","volume":"11","author":"H He","year":"2012","unstructured":"He H, Yang X, Lv X, et al. The difference of blood glucose fluctuation in type 2 diabetes mellitus patients with positive and negative insulin autoantibodies. Chin J Multiple Organ Dis Elderly. 2012;11:645\u20139.","journal-title":"Chin J Multiple Organ Dis Elderly"},{"issue":"8833","key":"658_CR20","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/0140-6736(92)92654-X","volume":"340","author":"Y Uchigata","year":"1992","unstructured":"Uchigata Y, Omori Y, Nieda M, et al. HLA-DR4 genotype and insulin-processing in insulin autoimmune syndrome. Lancet (London, England). 1992;340(8833):1467.","journal-title":"Lancet (London, England)"},{"issue":"10","key":"658_CR21","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2337\/diab.44.10.1227","volume":"44","author":"Y Uchigata","year":"1995","unstructured":"Uchigata Y, Tokunaga K, Nepom G, et al. Differential immunogenetic determinants of polyclonal insulin autoimmune syndrome (Hirata\u2019s disease) and monoclonal insulin autoimmune syndrome. Diabetes. 1995;44(10):1227\u201332.","journal-title":"Diabetes"},{"issue":"Pt 1","key":"658_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/0004563215590165","volume":"53","author":"AAA Ismail","year":"2016","unstructured":"Ismail AAA. Insulin analogues as a new example of interference in insulin assays. Ann Clin Biochem. 2016;53(Pt 1):181\u20132.","journal-title":"Ann Clin Biochem."},{"key":"658_CR23","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.diabres.2009.02.007","volume":"84","author":"T Ishizuka","year":"2009","unstructured":"Ishizuka T, Ogawa S, Mori T, et al. Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies. Diabetes Res Clin Pract. 2009;84:e21\u20133.","journal-title":"Diabetes Res Clin Pract"},{"key":"658_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1464-5491.2008.02621.x","volume":"26","author":"JR Greenfield","year":"2009","unstructured":"Greenfield JR, Tuthill A, Soos MA, et al. Severe insulin resistance due to anti-insulin antibodies: response to plasma exchange and immunosuppressive therapy. Diabet Med. 2009;26:79\u201382.","journal-title":"Diabet Med"},{"key":"658_CR25","first-page":"130086","volume":"2014","author":"N Jassam","year":"2014","unstructured":"Jassam N, Amin N, Holland P, et al. Analytical and clinical challenges in a patient with concurrent type 1 diabetes, subcutaneous insulin resistance and insulin autoimmune syndrome. Endocrinol Diabetes Metab Case Rep. 2014;2014:130086.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"658_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00000441-200505000-00007","volume":"329","author":"R Koyama","year":"2005","unstructured":"Koyama R, Nakanishi K, Kato M, et al. Hypoglycemia and hyperglycemia due to insulin antibodies against therapeutic human insulin: treatment with double filtration plasmapheresis and prednisolone. Am J Med Sci. 2005;329:259\u201364.","journal-title":"Am J Med Sci"},{"issue":"5","key":"658_CR27","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1210\/jc.2016-1097","volume":"101","author":"DR Saxon","year":"2016","unstructured":"Saxon DR, McDermott MT, Michels AW. Novel management of insulin autoimmune syndrome with rituximab and continuous glucose monitoring. J Clin Endocrinol Metab. 2016;101(5):1931\u20134.","journal-title":"J Clin Endocrinol Metab."},{"key":"658_CR28","first-page":"18","volume":"2018","author":"D Cappellani","year":"2018","unstructured":"Cappellani D, Sardella C, Campopiano MC, et al. Spontaneously remitting insulin autoimmune syndrome in a patient taking alpha-lipoic acid. Endocrinol Diabetes Metab Case Rep. 2018;2018:18\u20130122.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"10","key":"658_CR29","first-page":"830","volume":"12","author":"Z Jinyang","year":"2020","unstructured":"Jinyang Z, Fangfang Y, Sui Y, et al. Comparison of clinical characteristics between insulin autoimmune syndrome and exogenous insulin antibody syndrome. Chin J Diabetes Mellitus. 2020;12(10):830\u20134.","journal-title":"Chin J Diabetes Mellitus"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-021-00658-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13098-021-00658-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-021-00658-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T13:31:59Z","timestamp":1617802319000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-021-00658-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["658"],"URL":"https:\/\/doi.org\/10.1186\/s13098-021-00658-z","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"19 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}